FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

32570271000036106: Australian English language reference set (foundation metadata concept)

Status: current, Primitive. Date: 25-Dec 2013. Module: Australian common model component extension

Descriptions:

Id Description Lang Type Status Case? Module
108642501000036114 Australian English en Synonym Active Case sensitive Australian common model component extension
108644301000036110 Australian English language reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian common model component extension
108644311000036112 Australian English language reference set en Synonym Active Case sensitive Australian common model component extension
2171000036114 Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension
3306431000168118 ADRS - Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension

943353 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Australian dialect reference set Is a English true Inferred relationship Some
Members acceptabilityId
von Willebrand disease type IA Preferred
von Willebrand disease type IA Preferred
von Willebrand disease type IB Preferred
von Willebrand disease type IC Preferred
von Willebrand disease type III Acceptable
von Willebrand disease, platelet type Acceptable
von Willebrand disease, type 1^a^ Preferred
von Willebrand disease, type IIA Preferred
von Willebrand disease, type IIB Preferred
von Willebrand disease, type IIC Preferred
von Willebrand disease, type IID Preferred
von Willebrand disease, type IIE Preferred
von Willebrand disease, type IIF Preferred
von Willebrand disease, type IIG Preferred
von Willebrand disease, type IIH Preferred
von Willebrand disease, type IS/III Preferred
von Willebrand disorder Preferred
von Willebrand factor Preferred
von Willebrand factor Preferred
von Willebrand factor activity Preferred
von Willebrand factor activity Preferred
von Willebrand factor antibody Preferred
von Willebrand factor antigen Preferred
von Willebrand factor antigen Preferred
von Willebrand factor antigen (VWF:Ag) level Acceptable
von Willebrand factor antigen level Preferred
von Willebrand factor antigen level measurement Acceptable
von Willebrand factor collagen binding assay Preferred
von Willebrand factor inhibitor Acceptable
von Willebrand factor inhibitor disorder Preferred
von Willebrand factor level Preferred
von Willebrand factor level Preferred
von Willebrand factor multimer Preferred
von Willebrand factor multimer assay Preferred
von Willebrand factor multimeric analysis Preferred
von Willebrand factor only product Preferred
von Willebrand factor only product in parenteral dose form Preferred
von Willebrand factor products allergy Preferred
von Willebrand factor ristocetin cofactor Acceptable
von Willebrand factor ristocetin cofactor Preferred
von Willebrand factor-containing product Preferred
von Willebrand factor-containing product in parenteral dose form Preferred
von Willebrand receptor Preferred
von Willebrand screening test Preferred
von Willebrand's disease Preferred
von Willebrand's disease Acceptable
von Willebrand-Jurgens disease Acceptable
von Willebrand-Jürgens disease Acceptable
vonicog alfa Preferred
vonicog alfa Preferred
vonicog alfa 1300 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack Preferred
vonicog alfa 1300 units injection, vial Preferred
vonicog alfa 650 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack Preferred
vonicog alfa 650 units injection, vial Preferred
voretigene neparvovec Preferred
voretigene neparvovec Preferred
voretigene neparvovec 5 trillion vector genomes/mL injection [0.5 mL vial] (&) inert substance diluent [2 x 1.7 mL vials], 1 pack Preferred
voretigene neparvovec 5 trillion vector genomes/mL injection, 0.5 mL vial Preferred
vorhyaluronidase alfa Preferred
vorhyaluronidase alfa Preferred
vorhyaluronidase alfa 1600 units/10 mL injection, vial Preferred
vorhyaluronidase alfa 200 units/1.25 mL injection, vial Preferred
vorhyaluronidase alfa 2400 units/15 mL injection, vial Preferred
vorhyaluronidase alfa 400 units/2.5 mL injection, vial Preferred
vorhyaluronidase alfa 800 units/5 mL injection, vial Preferred
voriconazole Preferred
voriconazole Preferred
voriconazole 200 mg injection, 1 vial Preferred
voriconazole 200 mg injection, 5 vials Preferred
voriconazole 200 mg injection, vial Preferred
voriconazole 200 mg tablet Preferred
voriconazole 200 mg tablet, 10 Preferred
voriconazole 200 mg tablet, 100 Preferred
voriconazole 200 mg tablet, 14 Preferred
voriconazole 200 mg tablet, 2 Preferred
voriconazole 200 mg tablet, 20 Preferred
voriconazole 200 mg tablet, 28 Preferred
voriconazole 200 mg tablet, 30 Preferred
voriconazole 200 mg tablet, 50 Preferred
voriconazole 200 mg tablet, 56 Preferred
voriconazole 40 mg/mL powder for oral liquid Preferred
voriconazole 40 mg/mL powder for oral liquid, 70 mL Preferred
voriconazole 50 mg tablet Preferred
voriconazole 50 mg tablet, 10 Preferred
voriconazole 50 mg tablet, 100 Preferred
voriconazole 50 mg tablet, 14 Preferred
voriconazole 50 mg tablet, 2 Preferred
voriconazole 50 mg tablet, 20 Preferred
voriconazole 50 mg tablet, 28 Preferred
voriconazole 50 mg tablet, 30 Preferred
voriconazole 50 mg tablet, 50 Preferred
voriconazole 50 mg tablet, 56 Preferred
vorinostat Preferred
vorinostat Preferred
vorinostat 100 mg capsule Preferred
vorinostat 100 mg capsule, 120 Preferred
vortioxetine Preferred
vortioxetine Preferred
vortioxetine 10 mg tablet Preferred
vortioxetine 10 mg tablet, 28 Preferred
vortioxetine 15 mg tablet Preferred

Start Previous Page 9427 of 9434 Next End

Reference Sets

Reference set descriptor

Back to Start